Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients. (Q46816653)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

3

Przemyslaw Rutkowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

6

Boleslaw Rutkowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

Wieslawa Lysiak-Szydlowska

9 January 2020

series ordinal

5

object named as

Wieslawa Lysiak-Szydlowska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

Marcin Renke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Klaudiusz Wojnarowski

series ordinal

4

object named as

Klaudiusz Wojnarowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Urology and Nephrology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

511-517

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Combination ACEI and ARB therapy: additional benefit in renoprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

The role of tubulointerstitial injury in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Tubulo-interstitial damage in glomerular diseases: its role in the progression of the renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

The transforming growth factor beta system in kidney disease and repair: recent progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590510031264

10.1080/00365590510031264

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303729%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference